Back to search
Acute Respiratory Failure (ARF)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Respiratory Failure (ARF) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Acute Respiratory Failure (ARF) trials you may qualify forThis is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
This is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in…
Acute respiratory failure is a medical emergency rapidly leading to death, if not timely treated. Prompt Continuous Positive Airway Pressure (CPAP) improves pat…
Acute hypoxemic de novo respiratory failure (AHRF) is a common cause of admission to the intensive care unit (ICU). Its main cause is community-acquired pneumon…
Evaluation of awake prone position on ventilation inhomogeneity in COVID-19 associated respiratory failure.
The METEOR Trial will compare four implementation strategies-traditional online education, protocol-directed care, interprofessional education, and a combinatio…